News

Published on 15 Feb 2024 on Zacks via Yahoo Finance

What Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?


Article preview image

Momentum investing is all about the idea of following a stock's recent trend, which can be in either direction. In the 'long' context, investors will essentially be "buying high, but hoping to sell even higher." And for investors following this methodology, taking advantage of trends in a stock's price is key; once a stock establishes a course, it is more than likely to continue moving in that direction. The goal is that once a stock heads down a fixed path, it will lead to timely and profitable trades.

Even though momentum is a popular stock characteristic, it can be tough to define. Debate surrounding which are the best and worst metrics to focus on is lengthy, but the Zacks Momentum Style Score, part of the Zacks Style Scores, helps address this issue for us.

Below, we take a look at MorphoSys AG Unsponsored ADR (MOR), a company that currently holds a Momentum Style Score of B. We also talk about price change and earnings estimate revisions, two of the main aspects of the Momentum Style Score.

NASDAQ.MOR price evolution

Want to become a better investor?

Start tracking your investments with Statfolio

Sign up for free
Related News
MorphoSys (ETR:MOR) shareholders have earned a 228% return over the last year

When you buy shares in a company, there is always a risk that the price drops to zero. But if you...

Simply Wall St. via Yahoo Finance 10 May 2024

MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript

MorphoSys AG (NASDAQ:MOR) Q4 2023 Earnings Call Transcript March 14, 2024 MorphoSys AG isn't one ...

Insider Monkey via Yahoo Finance 15 Mar 2024

MorphoSys AG Unsponsored ADR (MOR) is a Great Momentum Stock: Should You Buy?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 4 Mar 2024

What Makes MorphoSys AG Unsponsored ADR (MOR) a Strong Momentum Stock: Buy Now?

Momentum investing is all about the idea of following a stock's recent trend, which can be in eit...

Zacks via Yahoo Finance 15 Feb 2024

30 Countries with Highest Standard of Living Ranked by GDP (PPP) Per Capita

In this article, we will look into the 30 countries with highest standard of living ranked by GDP...

Insider Monkey via Yahoo Finance 14 Feb 2024

Germany stocks lower at close of trade; DAX down 0.95% By Investing.com

Germany stocks lower at close of trade; DAX down 0.95%

Investing.com 14 Feb 2024

Gilead (GILD) to Buy CBAY for $4.3B, Add PBC Drug to Pipeline

Gilead Sciences, Inc. GILD announced that it will acquire clinical-stage biopharmaceutical compan...

Zacks via Yahoo Finance 13 Feb 2024

Deal Watch: Wachtell, Paul Weiss and V&E Lead $26B Oil Merger as Deal Activity Soars | The American...

Energy and life sciences continue to lead the way in deal activity, but tech and other recently...

Law.com 12 Feb 2024

Pharma Stock Roundup: AZN & LLY's Q4 Earnings, NVO, NVS & MRK's M&A Deals

The fourth-quarter earnings season entered its last lap this week, with Eli Lilly LLY and AstraZe...

Zacks via Yahoo Finance 9 Feb 2024

Novartis To Acquire MorphoSys AG

The agreement, which is still subject to closing conditions, says that Novartis will pay about $7...

Pharmaceutical Executive Magazine 7 Feb 2024